CVRM Disease Area Leader — Strategy & Portfolio Growth

At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters. The Position Our Global Pharma Strategy (GPS) team plays a pivotal role in shaping the future of healthcare by driving the strategic direction of our innovative product portfolio. As a member of the GPS team, you will be at the forefront of transforming groundbreaking scientific discoveries into accessible and impactful healthcare solutions for patients worldwide. We are seeking a dynamic and visionary professional who thrives in a collaborative environment and is passionate about making a difference. The Disease Area Leader - Cardiovascular, Renal and Metabolism (CVRM) role is critical to deliver on our Pharma Ambition. As the therapeutic area Late-Stage conduit into our early development teams, the Disease Area Leader plays a unique role in providing strategic insights and commercialization perspective to shape and steward our portfolio and create clarity on path to value, in particular through contribution to Asset and Disease Area Strategies and Business Development assessments. The Opportunity Partner with R&Ds units and cross-functionally to ensure organizational alignment around understanding of future disease area context as an Asset Team member for Research and Early Development (REDs). Ensure pipeline Asset strategies and Disease Strategies reflect value to patients, society, and Roche. Provide global strategic guidance and business inputs into the development of Target Product Profiles and Clinical Development Plans with a strong emphasis on value demonstration for pipeline molecules until PivGo or LCL assigned. Lead a cross-functional end-to-end team in the development and maintenance of disease area strategies that reflect near and long term pipeline portfolio evolution. Represent GPS in assessment of external landscape and partnering opportunities in the context of Disease Area Strategies as the Partnering GPS TA SPOC. Provide specific asset and platform/technology business input, path to value assessments, and strategic guidance to support due diligence. Lead the integrated development and commercialization planning (IDCP) process in partnership with CLT to bring affiliate inputs into asset and disease area strategies and decision making. Who You Are Possess scientific and commercial understanding of the therapeutic area, particularly in the prioritized disease area, ideally with an established network of external stakeholders and experience in development, portfolio, partnering, or medical affairs. Hold an MBA, MD, PhD, or other relevant Graduate or Postgraduate Degree. Demonstrate outstanding VACC (Visionary, Architect, Catalyst, and Coach) leadership skills with a proven track record in building teams and influencing collaboratively within a cross-functional environment. Exhibit exceptional strategic orientation and agility, with the ability to develop long-term vision and apply a deep understanding of the global pharmaceutical/biotechnology industry to create innovative business strategies. Show proven abilities to lead and deliver in a complex matrix environment across multiple priorities, with extensive experience in commercialization strategies, global health systems, and product life-cycle management. Ready for the next step? We look forward to hearing from you. Apply now to discover this exciting opportunity! Where pay transparency applies, details are provided based on the primary posting location. For this role, the primary location is Basel. If you are interested in additional locations where the role may be available, we will provide the relevant compensation details later in the hiring process. Who we are A healthier future drives us to innovate. Together, more than 100?000 employees across the globe are dedicated to advance science, ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities, foster creativity, and keep our ambitions high, so we can deliver life-changing healthcare solutions that make a global impact. Let's build a healthier future, together. Roche is an Equal Opportunity Employer. #J-18808-Ljbffr Roche